 | • レポートコード：MRC2312MG14609 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥455,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥682,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のヘルスケア・ナノ医療市場規模と予測を収録しています。・世界のヘルスケア・ナノ医療市場：売上、2018年-2023年、2024年-2029年 ・世界のヘルスケア・ナノ医療市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のヘルスケア・ナノ医療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ナノ粒子医薬品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ヘルスケア・ナノ医療のグローバル主要企業は、Amgen、 Teva Pharmaceuticals、 UCB、 Roche、 Celgene、 Sanofi、 Merck & Co、 Biogen、 Gilead Sciences、 Pfizer、 Leadiant Biosciences、 Kyowa Hakko Kirin、 Takeda、 Ipsen、 Endo Internationalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ヘルスケア・ナノ医療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のヘルスケア・ナノ医療市場：タイプ別、2018年-2023年、2024年-2029年 世界のヘルスケア・ナノ医療市場：タイプ別市場シェア、2022年 ・ナノ粒子医薬品、ナノキャリア医薬品 世界のヘルスケア・ナノ医療市場：用途別、2018年-2023年、2024年-2029年 世界のヘルスケア・ナノ医療市場：用途別市場シェア、2022年 ・抗癌剤、中枢神経系製剤、抗感染症剤、その他 世界のヘルスケア・ナノ医療市場：地域・国別、2018年-2023年、2024年-2029年 世界のヘルスケア・ナノ医療市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるヘルスケア・ナノ医療のグローバル売上、2018年-2023年 ・主要企業におけるヘルスケア・ナノ医療のグローバル売上シェア、2022年 ・主要企業におけるヘルスケア・ナノ医療のグローバル販売量、2018年-2023年 ・主要企業におけるヘルスケア・ナノ医療のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Amgen、 Teva Pharmaceuticals、 UCB、 Roche、 Celgene、 Sanofi、 Merck & Co、 Biogen、 Gilead Sciences、 Pfizer、 Leadiant Biosciences、 Kyowa Hakko Kirin、 Takeda、 Ipsen、 Endo International ************************************************************* ・調査・分析レポートの概要 ヘルスケア・ナノ医療市場の定義 市場セグメント 世界のヘルスケア・ナノ医療市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のヘルスケア・ナノ医療市場規模 世界のヘルスケア・ナノ医療市場規模：2022年 VS 2029年 世界のヘルスケア・ナノ医療市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのヘルスケア・ナノ医療の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のヘルスケア・ナノ医療製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：ナノ粒子医薬品、ナノキャリア医薬品 ヘルスケア・ナノ医療のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：抗癌剤、中枢神経系製剤、抗感染症剤、その他 ヘルスケア・ナノ医療の用途別グローバル売上・予測 ・地域別市場分析 地域別ヘルスケア・ナノ医療市場規模 2022年と2029年 地域別ヘルスケア・ナノ医療売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Amgen、 Teva Pharmaceuticals、 UCB、 Roche、 Celgene、 Sanofi、 Merck & Co、 Biogen、 Gilead Sciences、 Pfizer、 Leadiant Biosciences、 Kyowa Hakko Kirin、 Takeda、 Ipsen、 Endo International ... |
This research report provides a comprehensive analysis of the Healthcare Nanomedicine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Healthcare Nanomedicine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Healthcare Nanomedicine, challenges faced by the industry, and potential opportunities for market players.
The global Healthcare Nanomedicine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Healthcare Nanomedicine market presents opportunities for various stakeholders, including Anticancer, CNS Product. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Healthcare Nanomedicine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Healthcare Nanomedicine market was valued at US$ 189810 million in 2022 and is projected to reach US$ 380810 million by 2029, at a CAGR of 10.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Healthcare Nanomedicine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Healthcare Nanomedicine market.
Market Overview: The report provides a comprehensive overview of the Healthcare Nanomedicine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Nanoparticle Drug, Nanocarrier Drug), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Healthcare Nanomedicine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Healthcare Nanomedicine market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Healthcare Nanomedicine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Healthcare Nanomedicine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Healthcare Nanomedicine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Healthcare Nanomedicine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Healthcare Nanomedicine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Healthcare Nanomedicine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Healthcare Nanomedicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Nanoparticle Drug
Nanocarrier Drug
Market segment by Application
Anticancer
CNS Product
Anti-infective
Other
Global Healthcare Nanomedicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Amgen
Teva Pharmaceuticals
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Gilead Sciences
Pfizer
Leadiant Biosciences
Kyowa Hakko Kirin
Takeda
Ipsen
Endo International
Outline of Major Chapters:
Chapter 1: Introduces the definition of Healthcare Nanomedicine, market overview.
Chapter 2: Global Healthcare Nanomedicine market size in revenue.
Chapter 3: Detailed analysis of Healthcare Nanomedicine company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Healthcare Nanomedicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Healthcare Nanomedicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Healthcare Nanomedicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Healthcare Nanomedicine Overall Market Size
2.1 Global Healthcare Nanomedicine Market Size: 2022 VS 2029
2.2 Global Healthcare Nanomedicine Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Healthcare Nanomedicine Players in Global Market
3.2 Top Global Healthcare Nanomedicine Companies Ranked by Revenue
3.3 Global Healthcare Nanomedicine Revenue by Companies
3.4 Top 3 and Top 5 Healthcare Nanomedicine Companies in Global Market, by Revenue in 2022
3.5 Global Companies Healthcare Nanomedicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Healthcare Nanomedicine Players in Global Market
3.6.1 List of Global Tier 1 Healthcare Nanomedicine Companies
3.6.2 List of Global Tier 2 and Tier 3 Healthcare Nanomedicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Healthcare Nanomedicine Market Size Markets, 2022 & 2029
4.1.2 Nanoparticle Drug
4.1.3 Nanocarrier Drug
4.2 By Type – Global Healthcare Nanomedicine Revenue & Forecasts
4.2.1 By Type – Global Healthcare Nanomedicine Revenue, 2018-2023
4.2.2 By Type – Global Healthcare Nanomedicine Revenue, 2024-2029
4.2.3 By Type – Global Healthcare Nanomedicine Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Healthcare Nanomedicine Market Size, 2022 & 2029
5.1.2 Anticancer
5.1.3 CNS Product
5.1.4 Anti-infective
5.1.5 Other
5.2 By Application – Global Healthcare Nanomedicine Revenue & Forecasts
5.2.1 By Application – Global Healthcare Nanomedicine Revenue, 2018-2023
5.2.2 By Application – Global Healthcare Nanomedicine Revenue, 2024-2029
5.2.3 By Application – Global Healthcare Nanomedicine Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Healthcare Nanomedicine Market Size, 2022 & 2029
6.2 By Region – Global Healthcare Nanomedicine Revenue & Forecasts
6.2.1 By Region – Global Healthcare Nanomedicine Revenue, 2018-2023
6.2.2 By Region – Global Healthcare Nanomedicine Revenue, 2024-2029
6.2.3 By Region – Global Healthcare Nanomedicine Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Healthcare Nanomedicine Revenue, 2018-2029
6.3.2 US Healthcare Nanomedicine Market Size, 2018-2029
6.3.3 Canada Healthcare Nanomedicine Market Size, 2018-2029
6.3.4 Mexico Healthcare Nanomedicine Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Healthcare Nanomedicine Revenue, 2018-2029
6.4.2 Germany Healthcare Nanomedicine Market Size, 2018-2029
6.4.3 France Healthcare Nanomedicine Market Size, 2018-2029
6.4.4 U.K. Healthcare Nanomedicine Market Size, 2018-2029
6.4.5 Italy Healthcare Nanomedicine Market Size, 2018-2029
6.4.6 Russia Healthcare Nanomedicine Market Size, 2018-2029
6.4.7 Nordic Countries Healthcare Nanomedicine Market Size, 2018-2029
6.4.8 Benelux Healthcare Nanomedicine Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Healthcare Nanomedicine Revenue, 2018-2029
6.5.2 China Healthcare Nanomedicine Market Size, 2018-2029
6.5.3 Japan Healthcare Nanomedicine Market Size, 2018-2029
6.5.4 South Korea Healthcare Nanomedicine Market Size, 2018-2029
6.5.5 Southeast Asia Healthcare Nanomedicine Market Size, 2018-2029
6.5.6 India Healthcare Nanomedicine Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Healthcare Nanomedicine Revenue, 2018-2029
6.6.2 Brazil Healthcare Nanomedicine Market Size, 2018-2029
6.6.3 Argentina Healthcare Nanomedicine Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Healthcare Nanomedicine Revenue, 2018-2029
6.7.2 Turkey Healthcare Nanomedicine Market Size, 2018-2029
6.7.3 Israel Healthcare Nanomedicine Market Size, 2018-2029
6.7.4 Saudi Arabia Healthcare Nanomedicine Market Size, 2018-2029
6.7.5 UAE Healthcare Nanomedicine Market Size, 2018-2029
7 Healthcare Nanomedicine Companies Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Healthcare Nanomedicine Major Product Offerings
7.1.4 Amgen Healthcare Nanomedicine Revenue in Global Market (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 Teva Pharmaceuticals
7.2.1 Teva Pharmaceuticals Company Summary
7.2.2 Teva Pharmaceuticals Business Overview
7.2.3 Teva Pharmaceuticals Healthcare Nanomedicine Major Product Offerings
7.2.4 Teva Pharmaceuticals Healthcare Nanomedicine Revenue in Global Market (2018-2023)
7.2.5 Teva Pharmaceuticals Key News & Latest Developments
7.3 UCB
7.3.1 UCB Company Summary
7.3.2 UCB Business Overview
7.3.3 UCB Healthcare Nanomedicine Major Product Offerings
7.3.4 UCB Healthcare Nanomedicine Revenue in Global Market (2018-2023)
7.3.5 UCB Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Healthcare Nanomedicine Major Product Offerings
7.4.4 Roche Healthcare Nanomedicine Revenue in Global Market (2018-2023)
7.4.5 Roche Key News & Latest Developments
7.5 Celgene
7.5.1 Celgene Company Summary
7.5.2 Celgene Business Overview
7.5.3 Celgene Healthcare Nanomedicine Major Product Offerings
7.5.4 Celgene Healthcare Nanomedicine Revenue in Global Market (2018-2023)
7.5.5 Celgene Key News & Latest Developments
7.6 Sanofi
7.6.1 Sanofi Company Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Healthcare Nanomedicine Major Product Offerings
7.6.4 Sanofi Healthcare Nanomedicine Revenue in Global Market (2018-2023)
7.6.5 Sanofi Key News & Latest Developments
7.7 Merck & Co
7.7.1 Merck & Co Company Summary
7.7.2 Merck & Co Business Overview
7.7.3 Merck & Co Healthcare Nanomedicine Major Product Offerings
7.7.4 Merck & Co Healthcare Nanomedicine Revenue in Global Market (2018-2023)
7.7.5 Merck & Co Key News & Latest Developments
7.8 Biogen
7.8.1 Biogen Company Summary
7.8.2 Biogen Business Overview
7.8.3 Biogen Healthcare Nanomedicine Major Product Offerings
7.8.4 Biogen Healthcare Nanomedicine Revenue in Global Market (2018-2023)
7.8.5 Biogen Key News & Latest Developments
7.9 Gilead Sciences
7.9.1 Gilead Sciences Company Summary
7.9.2 Gilead Sciences Business Overview
7.9.3 Gilead Sciences Healthcare Nanomedicine Major Product Offerings
7.9.4 Gilead Sciences Healthcare Nanomedicine Revenue in Global Market (2018-2023)
7.9.5 Gilead Sciences Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Healthcare Nanomedicine Major Product Offerings
7.10.4 Pfizer Healthcare Nanomedicine Revenue in Global Market (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 Leadiant Biosciences
7.11.1 Leadiant Biosciences Company Summary
7.11.2 Leadiant Biosciences Business Overview
7.11.3 Leadiant Biosciences Healthcare Nanomedicine Major Product Offerings
7.11.4 Leadiant Biosciences Healthcare Nanomedicine Revenue in Global Market (2018-2023)
7.11.5 Leadiant Biosciences Key News & Latest Developments
7.12 Kyowa Hakko Kirin
7.12.1 Kyowa Hakko Kirin Company Summary
7.12.2 Kyowa Hakko Kirin Business Overview
7.12.3 Kyowa Hakko Kirin Healthcare Nanomedicine Major Product Offerings
7.12.4 Kyowa Hakko Kirin Healthcare Nanomedicine Revenue in Global Market (2018-2023)
7.12.5 Kyowa Hakko Kirin Key News & Latest Developments
7.13 Takeda
7.13.1 Takeda Company Summary
7.13.2 Takeda Business Overview
7.13.3 Takeda Healthcare Nanomedicine Major Product Offerings
7.13.4 Takeda Healthcare Nanomedicine Revenue in Global Market (2018-2023)
7.13.5 Takeda Key News & Latest Developments
7.14 Ipsen
7.14.1 Ipsen Company Summary
7.14.2 Ipsen Business Overview
7.14.3 Ipsen Healthcare Nanomedicine Major Product Offerings
7.14.4 Ipsen Healthcare Nanomedicine Revenue in Global Market (2018-2023)
7.14.5 Ipsen Key News & Latest Developments
7.15 Endo International
7.15.1 Endo International Company Summary
7.15.2 Endo International Business Overview
7.15.3 Endo International Healthcare Nanomedicine Major Product Offerings
7.15.4 Endo International Healthcare Nanomedicine Revenue in Global Market (2018-2023)
7.15.5 Endo International Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer